On October 11, 2010
With Meridia Gone, Can’t We Just Admit There’s No Money in Diet Drugs?
Analysts once thought obesity pharmaceuticals could be worth up to $10 billion in revenues per year but the reality is that it’s turned out to be a small fraction of that.
No tags for this post.
0 Comments